Compare SOS & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOS | EVGN |
|---|---|---|
| Founded | 2004 | 1999 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7M | 10.9M |
| IPO Year | 2017 | N/A |
| Metric | SOS | EVGN |
|---|---|---|
| Price | $1.39 | $1.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 43.6K | ★ 47.7K |
| Earning Date | 09-26-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $260,505,000.00 | $8,016,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.35 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 134.43 | 7.19 |
| 52 Week Low | $1.02 | $0.95 |
| 52 Week High | $9.62 | $2.42 |
| Indicator | SOS | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 50.59 | 43.17 |
| Support Level | $1.29 | $1.07 |
| Resistance Level | $1.56 | $1.12 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 65.56 | 42.11 |
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.